Employees need more than GLP-1s to manage their weight

Published Updated 4 Min Read

A woman with white tennis shoes, which take up the frame, is walking along a path alongside grass.
Adobe Stock

GLP-1s like Ozempic and Wegovy are all the rage now — and for patients with high blood sugar or at risk for obesity, they could be life-changing. But these medications are not a cure-all, and it seems consumers know that. 

Wondr Health, a weight management program provider, surveyed over 700 employees across 50 organizations about which factors are most important to consider when taking weight-loss medications: Lifestyle guidance ranked first with 78% of the votes, followed by medical guidance, overall effectiveness and potential side effects. 

Deanna Cuadra
Senior Reporter

Deanna Cuadra is a senior reporter at Employee Benefit News. Her work covers healthcare, U.S. policy and reform, challenges faced by women and parents in the workplace and innovation in work culture … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form